Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

fluorouracil

View Patient Information
An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. Fluorouracil and its metabolites possess a number of different mechanisms of action. In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth. Another active metabolite, 5-5-fluoro-2'-deoxyuridine-5'-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), one of the four nucleotide triphosphates used in the in vivo synthesis of DNA. Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both RNA processing and functions.
Synonym:5 fluorouracil
5 fluorouracilum
5-fluorouracil
5-Fluracil
Fluoro Uracil
fluouracil
Fluracil
US brand name:Carac
Foreign brand name:AccuSite
Flurablastin
Fluracedyl
Fluril
Fluroblastin
Ribofluor
Abbreviation:5 FU
5-FU
5-FU injection
5FU
FU
Code name:Ro-2-9757
Chemical structure:2,4-dioxo-5-fluoropyrimidine
5-fluoro-2,4(1H,3H)-pyrimidinedione
NSC code:19893
Search NCI's Drug Dictionary